( ARTG ) Metastatic Breast Cancer ABRAXANE is indicated for the treatment of metastatic carcinoma of the breast after failure of anthracycline therapy. Non-small Cell Lung Cancer ABRAXANE, in combination with carboplatin, is indicated for the first-line treatment of non-small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation.

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

• Caution should be exercised in patients with history of viral infection, HIV infection, heart, liver or kidney problems, bone marrow depression, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding. • It may cause dizziness or vision changes, do not drive a car or operate machinery while taking this medication. • Avoid alcohol c

OTC

HealthdirectFree Australian health advice you can count on.

INN: paclitaxel

Data updated: 2026-04-18

Available in:

🇨🇿🇬🇧🇫🇷🇯🇵🇵🇹🇷🇺🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.